Thromboprophylaxis in pregnant women with thrombophilia and thrombosis in past medical history
Author Affiliations1First Moscow State Medical University n.a. I.M. Sechenov of Minzdrav of Russia 109004, Moscow, Zemlyanoi Val str., 62, bd.1
2First Moscow State Medical University n.a. I.M. Sechenov of Minzdrav of Russia 109004, Moscow, Zemlyanoi Val str., 62, bd.1
3First Moscow State Medical University n.a. I.M. Sechenov of Minzdrav of Russia 109004, Moscow, Zemlyanoi Val str., 62, bd.1
4Maternity Hospital for Pregnants with Cardiovascular Diseases at Municipal Clinical Hospital #67 123423, Moscow, Salyam Adilya str., 2
5First Moscow State Medical University n.a. I.M. Sechenov of Minzdrav of Russia 109004, Moscow, Zemlyanoi Val str., 62, bd.1
6First Moscow State Medical University n.a. I.M. Sechenov of Minzdrav of Russia 109004, Moscow, Zemlyanoi Val str., 62, bd.1
Abstract
Modern data on etiopathogenesis, structure and clinical implications of thromboembolism complications during pregnancy at women with thrombosis and thrombophilia in past medical history have been performed. Thromboembolism of pulmonary artery takes the leading place in the structure of maternal mortality in developed countries. The method of thromb prophylaxis of pregnants including the application of low molecular weight heparins, B group vitamins and folic acid has been proposed. The safety and effectiveness of the proposed method have been evaluated.
Key words
References1. Avdonin P.V., Kirienko A.I., Kozhevnikova L.M. et al. C677T mutation in methylenetetrahydrofolate reductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism // Terapevticheskiy arkhiv. 2006. 78. (6). 70-76. (in Russian)
2. Makatsaria A.D., Bitsadze V.O. Thrombophilia and antithrombosis therapy in obstetrics. Moscow: Triada X, 2003. 904 p. (in Russian)
3. Abrahams V.M. Mechanisms of antiphospholipid antibody-associated pregnancy complications // Thromb. Res. 2009. 124. (5). 521-525.
4. Alferivic Z., Roberts D., Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome // Eur. J. Obstet. Gyencol. Reprod. Biol. 2002. 101. 6-14.
5. Anderson F.A.Jr., Spencer F.A. Risk factors for venous thromboembolism // Circulation. 2003. 107. 9-16.
6. Bick R.L., Frenkel E.P., Backer W.F., Sarode R. Hematological complications in obstetrics, pregnancy, and gynecology. Cambridge: University press. 2006. 604 p.
7. Brenner B. Haemostatic changes in pregnancy // Thromb. Res. 2004. 114. (5-6):409-14.
8. Den Heijer M., Lewington S., Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies // J. Thromb. Haemost. 2005. 3. (2). 292-299.
9. Dossenbach-Glaninger A., van Trotsenburg M., Dossenbach M. et al. Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss // Clin. Chem. 2003. 49. (7). 1081-1086.
10. Fabbro D., D'Elia A.V., Spizzo R. et al. Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia // Gynecol. Obstet. Invest. 2003. 56. (1). 17-22.
11. Forastiero R., Martinuzzo M. Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome // Lupus. 2008. 17. (10). 872-827.
12. Frederiksen J., Juul K., Grande P. et al. Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study // Blood. 2004. 104. (10). 3046-3051.
13. Gerhardt A., Scharf R.E., Beckmann M.W. et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium // N. Engl. J. Med. 2000. 342. (6). 374-380.
14. Ginsberg J.S., Bates S.M. Management of venous thromboembolism during pregnancy // J. Thromb. Haemost. 2003. 1. (7). 1435-1442.
15. Girling J., de Swiet M. Inherited thrombophilia and pregnancy // Curr. Opin. Obstet. Gynecol. 1998. 10. (2). 135-144.
16. Glueck C.J., Phillips H., Cameron D. et al. The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications // Metabolism. 2000. 49. (7). 845-852.
17. Goodnight S.H., Hathaway W.E. Disorders of haemostasis and thrombosis. Clinical guide. Second edition. McGraw-Hill, Inc., 2001. 622 p.
18. Greer I.A. Thrombophilia: implications for pregnancy outcome // Thromb. Res. 2003. 109. (2-3). 73-81.
19. Hirsh J., Guyatt G., Albers G.W. et al. Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) // Chest. 2008. 133. 110S-112S.
20. Kearon C., Gent M., Hirsh J. et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism // N. Engl. J. Med. 1999. 340. (12). 901-907.
21. Koniari I., Siminelakis S.N., Baikoussis N.G. et al. Antiphospholipid syndrome; its implication in cardiovascular diseases: a review // J. Cardiothorac. Surg. 2010. 5. 101.
22. Miyakis S., Lockshin M.D., Atsumi T. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) // J. Thromb. Haemost. 2006. 4. (2). 295-306.
23. Nicolaides A.N., Breddin H.K., Carpenter P. et al. Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence // Int Angiol. 2005. 24. (1). 1-26.
24. Pabinger I., Grafenhofer H., Kyrle P.A. et al. Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism // Blood. 2002. 100. (3). 1060-1062.
25. Rand J.H., Wu X.X. Antibody-mediated disruption of the annexin-V antithrombotic shield: A new mechanism for thrombosis in the antiphospholipid syndrome // Thromb. Hemost. 1999. 82. (2). 649-656.
26. Ray J.G., Chan W.S. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation // Obstet. Gynecol. Surv. 1999. 54. (4). 265-271.
27. Rey E., Kahn S.R., David M. et al. Thrombophilic disorders and fetal loss: a meta-analysis // Lancet. 2003. 361. 901-908.
28. Robertson L., Greer I. Thromboembolism in pregnancy // Curr. Opin. Obstet. Gynecol. 2005. 17. (2). 113-116.
29. Simioni P., Tormene D., Spiezia L. et al. Inherited thrombophilia and venous thromboembolism // Semin. Thromb. Hemost. 2006. 32. (7). 700-708.
About Authors (Correspondence):
Makatsaria A.D. - professor, corresponding member of RAMS, head of the chair of obstetrics and gynecology of medical-prophylactic faculty
Bitsadze V.O. - doctor of medical sciences, professor, professor of the chair of obstetrics and gynecology of medical-prophylactic faculty
Khizroeva D.Kh. - candidate of medical sciences, assistant of the chair of obstetrics and gynecology of medical-prophylactic faculty
Nemirovsky V.B. - chief physician
Gadaeva Z.K. - postgraduate student of the chair of obstetrics and gynecology of medical-prophylactic faculty
Akinshina S.V. - candidate of medical sciences, assistant of the chair of obstetrics and gynecology
of medical-prophylactic faculty
Full Text
